Innovative Pre-clinical Research

Synovo is a drug discovery company with a primary focus on inflammation and innate immune processes.
We are located in Tübingen, Germany which is both a major centre for basic research and also home to a vibrant bio-medical start-up scene.
We have two main business areas:

  • we provide drug discovery services in pharmacology, medicinal chemistry and bioanalytics, and,
  • we develop in-house novel therapeutics and related diagnostics

Our culture is focused on generating insight through inter-disciplinary, collaborative work with clients and partners.   
Within our team of nearly 50 people we have specialists in synthetic chemistry, pharmacology, analytics, immunology, neurology and biochemistry.  In addition, we have a broad network of research partners throughout the world collaborating with us in areas like basic disease mechanisms, drug formulation technology, surface modification and drug mode of action.

We welcome enquiries and we are proud of our reputation for helping colleagues and partners achieve their research goals. 

What we do

PHARMACEUTICAL SERVICES

Synovo offers the possibility of improving your pre-clinical data set. Take the opportunity to explore deeper parameters and learn more from your studies by adding our services to your projects.

Learn more about our

SERVICES

 

 

INNOVATION

We are committed to contribute to health improvement by developing novel therapeutic options for global unmet needs.

 

Learn more about our

PROJECTS

 

TEAM

The Synovo family shares a common interest toward developing science-driven mind changing ideas, by interdisciplinary and creative team work.

 

Latest news

BIO EUROPE

Meet us at BIO-EUROPE from November 5–7, 2018 in the Bella Center in beautiful Copenhagen. “The BIO-Europe 2018 partnering event is expected to draw over 4,000 industry attendees for three days of high level networking, representing more than 2,000 companies from over 60 countries.”

Kick-off meeting NACTAR

The official kick-off meeting for the program ‘Novel Antibacterial Compounds and Therapies Antagonizing Resistance’ (NACTAR) will be held in the Netherlands this September. #NACTAR #Synovo The project MDR-Phage brings together the expertise and resources from Synovo GmbH, Qualizyme Diagnostics, the University of Twente, and the University of Amsterdam. Within the project, we will test our […]

Synovo Soundtrack10k

The first edition of the Synovo Soundtrack10k was a huge success! About 350 runners went on the beautiful 3-lap-course along the Neckar river and finished the 10km-long race. Our own Karoline Degenhardt took second overall while TeamScience also took second in the team event. Synovo is happy to be able to be part of such […]

See all our news

We believe in

  • Research commitment. Users/patients focus. Quality and reliability.
  • Respect and integrity. Work-life balance.
  • Diversity.
  • Interdisciplinary team. Open and constant flow of knowledge.
  • Collaborative leadership. Transparent networking.
  • Flexibility and Creative Innovation. Challenge acceptance.
  • Education and training. Modern and traditional methods.
  • Personal growth and initiative.
Join in